No Data
After Losing 17% in the Past Year, Century Therapeutics, Inc. (NASDAQ:IPSC) Institutional Owners Must Be Relieved by the Recent Gain
Century Therapeutics (IPSC) Moves to Buy: Rationale Behind the Upgrade
Century Therapeutics(IPSC.US) Officer Sells US$14,178.5 in Common Stock
$Century Therapeutics(IPSC.US)$ Officer Russotti Gregory sold 5,000 shares of common stock on Jun 20, 2024 at an average price of $2.8357 for a total value of $14,178.5.Source: Announcement What is st
Express News | Century Therapeutics Files For Shelf Of Up To 7.9M Shares Of Common Stock By Selling Stockholders
Express News | Century Therapeutics Inc Files for Shelf of up to 7.9 Mln Shares of Common Stock by Selling Stockholders - SEC Filing
Century Therapeutics Is Maintained at Overweight by Piper Sandler
Century Therapeutics Is Maintained at Overweight by Piper Sandler